🎁Capturing Top 10 Ex_dividend: WSO, AIV, GHC, PNC, ABBV...
1. Which High Ex-dividend Stock (on 13 October ~ 17 October) do You Like the Most?
Be Sure To Check Out the Last Chance to Buy the Top 10 High dividend stocks going to Ex-dividends This Week: many companies like $Watsco(WSO)$ $ and $Apartment Investment & Management(AIV)$ showing below are about to give decent dividends into "your pocket".
Editor's notes:
A dividend-paying stock ex-dividend date, or ex-date, is very important to investors. In a nutshell, if you buy a dividend stock before the ex-dividend date, then you will receive the next upcoming dividend payment.
If you purchase the stock on or after the ex-dividend date, you will not receive the dividend. Some investors utilize strategies whereby they will purchase stocks just prior to an ex-dividend date and sell shortly thereafter.
2. YTD25 of the Above 10 Stocks are as Below:
According to TradingView’s 2025 data, several companies including $Graham(GHC)$, $AbbVie(ABBV)$ ,$American(AFG)$, $City(CHCO)$ ,$Elbit Systems Ltd(ESLT)$,$Abbott Laboratories(ABT)$ )recorded notable gains, while others such as $Watsco(WSO)$ $Apartment Investment & Management(AIV)$ , $PNC Financial Services Group Inc(PNC)$, $Mid-America Apartment Communities(MAA)$ posted declines.
3. Reply to Win Tiger Coins
Which stock above do you like the most? Why?
Please find the Analyst Price Target of the mentioned stocks from Tiger Trade "Analysis".
Any other companies going to ex_dividend this week you are interested in?
🎁Prizes
🐯 All valid comment on the following post will receive 5 Tiger Coins.
🐯 The Top 3 comments with the most likes will get another 10 Tiger Coins.
(Event Duration: Now - 20 October 2025)
(Coins and vouchers will be sent to you within 20 working days after the event ends.)
For SG users only, a tool to boost your purchasing power and trading ideas with a Cash Boost Account!
Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.
Other helpful links:
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
I’m also confident in AbbVie’s product lineup & pipeline. While Humira’s decline was a concern, newer drugs like Skyrizi and Rinvoq have delivered strong sales, helping offset loss & drive future growth. The company’s focus on immunology, oncology, & neuroscience keeps it well-positioned for continued innovation & profitability.
Lastly, AbbVie offers an appealing valuation and outlook. It remains reasonably priced with positive analyst sentiment. I like that it provides both stable income and potential capital appreciation — making AbbVie a balanced, dependable pick in a volatile market.
@Tiger_comments @TigerStars @Tiger_Earnings